Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors (Q83367527)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 May 2006
edit
Language Label Description Also known as
English
Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors
scientific article published on 01 May 2006

    Statements

    title
    Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    16710023
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710023%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    21 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q83367527&oldid=1433411725"